| Robert C Kolodny, MD | |
|
57 The Flume, Amherst, NH 03031-1520 | |
| (203) 981-8424 | |
| (603) 672-4495 |
| Full Name | Robert C Kolodny |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 57 The Flume, Amherst, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144560483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 024157 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert C Kolodny, MD 57 The Flume, Amherst, NH 03031-1520 Ph: (203) 981-8424 | Robert C Kolodny, MD 57 The Flume, Amherst, NH 03031-1520 Ph: (203) 981-8424 |
News Archive
Every hour, an enormous quantity and variety of manmade chemicals, having reached the end of their useful lifespan, flood into wastewater treatment plants. These large-scale processing facilities, however, are designed only to remove nutrients, turbidity and oxygen-depleting human waste, and not the multitude of chemicals put to residential, institutional, commercial and industrial use.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
Matt Salmon, President of the Electronic Cigarette Association (ECA), today denounced a quotation attributed to him by Epiphany Media Group in a press release dated September 14, 2009. The falsely attributed quotation conveys the mistaken impression that some e-cigarette products have been approved by the FDA for consumer use. Salmon underscored the ECA's commitment to abide by FDA regulations.
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.
Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more comprehensive gene sequencing technology to type human leukocyte antigens (HLAs)-complex, highly variable proteins on cell surfaces that are essential to immune function.
› Verified 6 days ago
Dr. Catherine Anne Booher, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 16 Nathan Lord Rd, Amherst, NH 03031 Phone: 410-236-6520 | |
Dr. Teresa White Tranchemontagne, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8 Limbo Lane, Amherst, NH 03031 Phone: 603-673-5885 Fax: 603-672-7150 |